MedTrace Logo

Integrated Learning Support System Based on Immersive Simulated Training for Nursing Students

NCT06472401 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2024-07-31

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of an Integrated Learning Support System (ILSS) in preparing undergraduate nursing students for immersive simulated training in managing drug-induced nephrotoxicity. The study hypothesizes that the ILSS, which accommodates different learning styles, will be more effective in reducing stress and anxiety compared to the standard learning model (SLM). The research will involve a parallel randomized controlled trial with 96 students from two Brazilian institutions. The students will be divided into control and experimental groups, with the latter using the ILSS in addition to SLM during preparation. The study will assess outcomes such as knowledge acquisition, skill development, and stress reduction using various instruments, including the Lasater Clinical Judgment Rubric and DASS-21. The study's findings aim to validate the ILSS as a tool to enhance learning outcomes and reduce stress and anxiety, thereby promoting better professional development and patient safety in nursing practice.

Conditions

  • Simulation Training
  • Learning
  • Educational Technology
  • Nephrotoxicity
  • Physiological Stress

Interventions

OTHER

Integrated Learning Support System

Students will receive simulation preparation with an Integrated Learning Support System consisting of: * Educational technology in comic book format * Virtual monitoring system with tutors * Psychological follow-up * Music listening and relaxation session

OTHER

Standard Learning Model

Students will receive standard simulation preparation consisting of: \- Expository and dialogued theoretical class.

Sponsors & Collaborators

  • University of Brasilia

    lead OTHER

Principal Investigators

  • Marcia CS Magro, PhD · University of Brasilia

  • Breno S Santana, MsC · University of Brasilia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-07-31
Completion
2025-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06472401 on ClinicalTrials.gov